甲磺酸阿帕替尼联合抗PD-1抗体（SHR-1210）对化疗失败的进展期骨肉瘤有效性和安全性的单臂、开放、前瞻性、单中心临床研究中期汇报 （clinicaltrials注册号：NCT03359018）
讲者：谢璐
单位：北京大学人民医院
Optimize multimodality care in locally advanced non-small cell lung cancer
讲者：Hak Choy
单位：MD, FASTRO (University of Texas Southwestern Medical Center, USA)
Challenge of front line immunotherapy for advanced NSCLC
讲者：Hossein Borghaei
单位：MD, (Fox Chase Cancer Center, USA)
